Plain-English translation of NCT07268833 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to find new ways to detect ALS earlier by looking for disease markers in skin biopsies and blood samples. This study will enroll 400 people—including those with ALS, family members at genetic risk, people with other nerve diseases, and healthy controls—to discover patterns that could become simple blood tests for diagnosing ALS before symptoms get worse.
ALS is a devastating disease with no cure, and doctors today don't have reliable early warning signs to catch it quickly. This research aims to identify new biomarkers—measurable signs of disease—that could help detect ALS much earlier and lead to new treatments that might slow or stop the disease.
You likely qualify if…
You likely don't qualify if…
You will undergo a small skin biopsy (a minimally invasive sample of nerve tissue from the skin) and provide blood samples that researchers will analyze for disease markers. Your samples will be compared with those from other participants to identify patterns specific to ALS and other conditions, helping create new diagnostic tests that patients and doctors could use in the future.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Italy